Prof Ed Stanley
Prof Ed Stanley
Details
Role
Dep. Theme Director - Stem Cell Biology
Research area
Stem Cell Medicine
Group
Immune Development
Contact
Available for student supervision
Professor Ed Stanley is the Group Leader of the Immune Development Laboratory at the Murdoch Children’s Research Institute (MCRI). His laboratory uses human pluripotent stem cells to study human immunity and autoimmune diseases, such as type 1 diabetes. In a long standing collaboration with Professor Andrew Elefanty and Dr Elizabeth Ng (Blood Development Laboratory) at MCRI, Prof Stanley has contributed to the development of underpinning technologies relating to the use of human pluripotent stem cells as an experimental platform, encompassing the genetic modification of human pluripotent stem cell lines, differentiation platforms and cell culture medium formulations.
Following completion of his PhD in Molecular Biology at the University of Melbourne / Ludwig Institute, he worked on embryonic stem cells and haematopoietic development under the supervision of Professor Ashley Dunn, Ludwig Institute, Melbourne, Australia. He was awarded a C.J. Martin Fellowship to undertake postdoctoral training in the laboratory or Prof Peter Rigby at the National Institute of Medical Research in London, before retuning to Prof Richard Harvey’s group at the Walter and Eliza Hall Institute in Melbourne, where he worked on cardiogenesis and embryonic stem cells. Prof Stanley moved Monash University in 2002 to jointly head the Embryonic Stem Cell Differentiation Laboratory and build expertise in human embryonic stem cell genetic modification and differentiation. His laboratory relocated to the MCRI in 2012, where he has continued his long-standing collaboration with Prof Andrew Elefanty and Dr Elizabeth Ng, working on the haematopoietic, endocrine and immune development. Professor Stanley is currently deputy leader of the Stem Cell Biology Theme at MCRI and deputy director of Melbourne node of the reNEW Centre for Stem Cell Medicine supported by the Novo Nordisk Foundation.
Prof Ed Stanley holds active collaborations with:
• Dr Elizabeth Ng, Blood Development Laboratory, MCRI
• Prof Andrew Elefanty, Blood Development Laboratory, MCRI
• A/ Prof Stuart Mannering, Immunology Laboratory, St Vincent's Institute of Medical Research
• Prof Fergus Cameron, Endocrinology and Diabetes, The Royal Children's Hospital Melbourne
• A/Prof Dan Pellicci, Cellular Immunity Laboratory, MCRI
• A/Prof Sarah Londrigan, Senior Lecturer Virology and Group Leader, Doherty Institute.
Following completion of his PhD in Molecular Biology at the University of Melbourne / Ludwig Institute, he worked on embryonic stem cells and haematopoietic development under the supervision of Professor Ashley Dunn, Ludwig Institute, Melbourne, Australia. He was awarded a C.J. Martin Fellowship to undertake postdoctoral training in the laboratory or Prof Peter Rigby at the National Institute of Medical Research in London, before retuning to Prof Richard Harvey’s group at the Walter and Eliza Hall Institute in Melbourne, where he worked on cardiogenesis and embryonic stem cells. Prof Stanley moved Monash University in 2002 to jointly head the Embryonic Stem Cell Differentiation Laboratory and build expertise in human embryonic stem cell genetic modification and differentiation. His laboratory relocated to the MCRI in 2012, where he has continued his long-standing collaboration with Prof Andrew Elefanty and Dr Elizabeth Ng, working on the haematopoietic, endocrine and immune development. Professor Stanley is currently deputy leader of the Stem Cell Biology Theme at MCRI and deputy director of Melbourne node of the reNEW Centre for Stem Cell Medicine supported by the Novo Nordisk Foundation.
Prof Ed Stanley holds active collaborations with:
• Dr Elizabeth Ng, Blood Development Laboratory, MCRI
• Prof Andrew Elefanty, Blood Development Laboratory, MCRI
• A/ Prof Stuart Mannering, Immunology Laboratory, St Vincent's Institute of Medical Research
• Prof Fergus Cameron, Endocrinology and Diabetes, The Royal Children's Hospital Melbourne
• A/Prof Dan Pellicci, Cellular Immunity Laboratory, MCRI
• A/Prof Sarah Londrigan, Senior Lecturer Virology and Group Leader, Doherty Institute.
Professor Ed Stanley is the Group Leader of the Immune Development Laboratory at the Murdoch Children’s Research Institute (MCRI). His laboratory uses human pluripotent stem cells to study human immunity and autoimmune diseases, such as type 1...
Professor Ed Stanley is the Group Leader of the Immune Development Laboratory at the Murdoch Children’s Research Institute (MCRI). His laboratory uses human pluripotent stem cells to study human immunity and autoimmune diseases, such as type 1 diabetes. In a long standing collaboration with Professor Andrew Elefanty and Dr Elizabeth Ng (Blood Development Laboratory) at MCRI, Prof Stanley has contributed to the development of underpinning technologies relating to the use of human pluripotent stem cells as an experimental platform, encompassing the genetic modification of human pluripotent stem cell lines, differentiation platforms and cell culture medium formulations.
Following completion of his PhD in Molecular Biology at the University of Melbourne / Ludwig Institute, he worked on embryonic stem cells and haematopoietic development under the supervision of Professor Ashley Dunn, Ludwig Institute, Melbourne, Australia. He was awarded a C.J. Martin Fellowship to undertake postdoctoral training in the laboratory or Prof Peter Rigby at the National Institute of Medical Research in London, before retuning to Prof Richard Harvey’s group at the Walter and Eliza Hall Institute in Melbourne, where he worked on cardiogenesis and embryonic stem cells. Prof Stanley moved Monash University in 2002 to jointly head the Embryonic Stem Cell Differentiation Laboratory and build expertise in human embryonic stem cell genetic modification and differentiation. His laboratory relocated to the MCRI in 2012, where he has continued his long-standing collaboration with Prof Andrew Elefanty and Dr Elizabeth Ng, working on the haematopoietic, endocrine and immune development. Professor Stanley is currently deputy leader of the Stem Cell Biology Theme at MCRI and deputy director of Melbourne node of the reNEW Centre for Stem Cell Medicine supported by the Novo Nordisk Foundation.
Prof Ed Stanley holds active collaborations with:
• Dr Elizabeth Ng, Blood Development Laboratory, MCRI
• Prof Andrew Elefanty, Blood Development Laboratory, MCRI
• A/ Prof Stuart Mannering, Immunology Laboratory, St Vincent's Institute of Medical Research
• Prof Fergus Cameron, Endocrinology and Diabetes, The Royal Children's Hospital Melbourne
• A/Prof Dan Pellicci, Cellular Immunity Laboratory, MCRI
• A/Prof Sarah Londrigan, Senior Lecturer Virology and Group Leader, Doherty Institute.
Following completion of his PhD in Molecular Biology at the University of Melbourne / Ludwig Institute, he worked on embryonic stem cells and haematopoietic development under the supervision of Professor Ashley Dunn, Ludwig Institute, Melbourne, Australia. He was awarded a C.J. Martin Fellowship to undertake postdoctoral training in the laboratory or Prof Peter Rigby at the National Institute of Medical Research in London, before retuning to Prof Richard Harvey’s group at the Walter and Eliza Hall Institute in Melbourne, where he worked on cardiogenesis and embryonic stem cells. Prof Stanley moved Monash University in 2002 to jointly head the Embryonic Stem Cell Differentiation Laboratory and build expertise in human embryonic stem cell genetic modification and differentiation. His laboratory relocated to the MCRI in 2012, where he has continued his long-standing collaboration with Prof Andrew Elefanty and Dr Elizabeth Ng, working on the haematopoietic, endocrine and immune development. Professor Stanley is currently deputy leader of the Stem Cell Biology Theme at MCRI and deputy director of Melbourne node of the reNEW Centre for Stem Cell Medicine supported by the Novo Nordisk Foundation.
Prof Ed Stanley holds active collaborations with:
• Dr Elizabeth Ng, Blood Development Laboratory, MCRI
• Prof Andrew Elefanty, Blood Development Laboratory, MCRI
• A/ Prof Stuart Mannering, Immunology Laboratory, St Vincent's Institute of Medical Research
• Prof Fergus Cameron, Endocrinology and Diabetes, The Royal Children's Hospital Melbourne
• A/Prof Dan Pellicci, Cellular Immunity Laboratory, MCRI
• A/Prof Sarah Londrigan, Senior Lecturer Virology and Group Leader, Doherty Institute.
Top Publications
- Nafria, M, Keane, P, Ng, ES, Stanley, EG, Elefanty, AG, Bonifer, C. RUNX1-ETO induction rapidly alters chromatin landscape and growth of a specific sub-population of hESC-derived myeloid precursor cells by interfering with RUNX1 regulation. 2024 view publication
- Joglekar, MV, Sahu, S, Wong, WK, Satoor, SN, Dong, CX, Farr, RJ, Williams, MD, Pandya, P, Jhala, G, Yang, SNY, et al. A pro-endocrine pancreatic transcriptional program established during development is retained in human gallbladder epithelial cells. 2024 view publication
- Lokmic, Z, Ng, ES, Burton, M, Stanley, EG, Penington, AJ, Elefanty, AG. Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting. Journal of Visualized Experiments 2024 view publication
- Perriman, L, Tavakolinia, N, Jalali, S, Li, S, Hickey, PF, Amann-Zalcenstein, D, Ho, WWH, Baldwin, TM, Piers, AT, Konstantinov, IE, et al. A three-stage developmental pathway for human Vγ9Vδ2 T cells within the postnatal thymus.. Sci Immunol 8(85) : eabo4365 2023 view publication
- Vlahos, K, Sourris, K, Yi Kuah, J, Graham, A, Suter, A, Howden, SE, Stanley, EG, Elefanty, AG. Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors.. Stem Cell Res 69: 103109 2023 view publication
Page 1 of 36
Career information
Share //
